Loading chat...
CT SB00440
Bill
Status
3/7/2018
Primary Sponsor
Human Services Committee
Click for details
AI Summary
-
Requires the Commissioner of Social Services to provide Medicaid coverage for pharmacogenomics tests (genetic testing to determine how individuals respond to prescription drugs) determined medically necessary by a treating primary care practitioner, to the extent permissible under federal law
-
Eliminates prior authorization requirements for medically necessary pharmacogenomics tests for persons being treated for behavioral disorders, psychiatry disorders, cardiovascular disorders, and chronic pain
-
Allows the commissioner to preferentially contract with Medicaid-enrolled laboratory providers offering discounted prices for pharmacogenomics tests
-
Permits the commissioner to amend the Medicaid state plan if necessary to provide coverage for pharmacogenomics tests
-
Effective July 1, 2018
Legislative Description
An Act Concerning Coverage Of Pharmacogenomics Testing Under The Husky Health Programs.
Last Action
Public Hearing 03/15
3/9/2018